Journey Medical Corporation DERM
6.14
(0.18)
(2.85%)
as of 25 Sep
- Market cap
- $178.4M
- P/E
- 0.0×
Follow DERM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(47.05%) | (44.03%) | (36.61%) | (23.77%) | |
| (11.61%) | (13.08%) | (10.86%) | (6.80%) | ||
ROIC |
(13.15%) | (15.46%) | (13.67%) | (5.89%) | |
Return on Tangible Assets |
(51.96%) | (38.84%) | (35.33%) | (22.60%) | |
Average Days of Receivables |
110.50 | 175.74 | 141.03 | 194.04 | |
Free Cash Flow per Share |
(0.16) | (0.51) | (0.25) | (0.27) | |
Free Cash Flow |
(3.93) | (12.44) | (6.70) | (7.49) | |
Piotroski F-Score |
4.00 | 4.00 | 5.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(5.17%) | (15.32%) | (8.03%) | (9.00%) | |
Accounts Receivable Turnover |
4.15 | 3.09 | 3.01 | 2.63 | |
Accounts Payable Turnover |
1.44 | 1.68 | 1.94 | 2.18 | |
Inventory Turnover |
1.71 | 1.74 | 2.05 | 2.24 | |
Average Days of Payables |
222.88 | 154.40 | 133.94 | 124.72 | |
Days of Inventory on Hand |
213.93 | 167.88 | 151.74 | 126.38 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.01 | |
Research and Development Expense of Revenue |
0.92% | 0.78% | 0.68% | 0.73% | |
Selling, General and Administrative Expense of Revenue |
75.03% | 71.73% | 67.88% | 62.94% | |
Share Based Compensation of Revenue |
9.92% | 10.17% | 9.21% | 8.88% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.45 | 1.09 | 0.70 | 1.23 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
2.38 | 2.53 | 2.37 | 2.48 | |
Operating CF per Share |
(0.16) | (0.51) | (0.25) | (0.27) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(14.58%) | (18.48%) | (14.82%) | (8.95%) |
Columns are period end dates